A study published in Chinese Medical Journal reveals potential of methotrexate to treat liver cancer
The study provides evidence suggesting that this widely used chemotherapeutic drug could be repurposed for treating a subtype of hepatocellular carcinoma
2023-09-20
(Press-News.org)
Liver cancer is one of the most prevalent and deadly types of cancer worldwide. Most patients are diagnosed at an advanced stage, which leaves them with few treatment options. Unfortunately, the first-line drugs used in advanced hepatocellular carcinoma (HCC), the most common type of liver cancer, are not very effective and offer only modest clinical benefits.
Over the past few years, scientists have been trying to develop new therapies for HCC by analyzing specific genetic abnormalities and the ways in which they affect the manifestation and progression of the disease. One of the most common mutations in HCC occurs in CTNNB1 gene, which encodes a protein called β-catenin. The mutated version of this protein is resistant to degradation, causing it to accumulate in the affected cells. Over time, excess β-catenin dysregulates the Wnt signaling pathway, which triggers uncontrolled cell proliferation. However, no therapies targeting β-catenin-related pathways have been approved yet.
Against this backdrop, a research team including Dr. Hongbing Zhang from the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, China, has adopted a different approach. In their latest study, made available online on 23 August 2023 and published in the Chinese Medical Journal, the researchers sought to determine whether existing chemotherapy drugs could be effective for treating β-catenin-activated liver cancer. “Repurposing old drugs is an attractive strategy because it lowers overall drug development costs and shortens development timelines,” states Dr. Zhang.
With this goal, the researchers first conducted a screening experiment using 12 widely used chemotherapeutic drugs. Employing both genetically modified cells in culture and mice inoculated with subcutaneous tumors expressing the mutated CTNNB1 gene, they found that methotrexate (MTX), a widely used drug for treating conditions such as psoriasis, rheumatoid arthritis, and certain types of cancer, was particularly effective against β-catenin-activated cells. The efficacy and selectivity of MTX were further validated on β-catenin-activated human liver cancer cells in vitro and in vivo.
After that, the team investigated the underlying mechanisms that made MTX effective against β-catenin-activated cells. Interestingly, MTX does not directly affect β-catenin signaling. The analysis of the specific metabolic changes produced by this drug revealed that it represses β-catenin-boosted nucleotide synthesis that leads to malignancy. “MTX, a folic acid antagonist, is an inhibitor of nucleotide metabolism. It blocks the conversion of dihydrofolate to tetrahydrofolate, thereby hindering nucleotide synthesis in proliferating cancer cells,” explains Dr. Zhang. Further experiments showed that the dysregulated β-catenin-activated nucleotide synthesis itself sensitizes the mutant cells to MTX treatment in the first place.
HBV (hepatitis B virus)-induced chronic hepatitis is the major risk factor of HCC. To make the animal model experiments more clinically relevant, the researchers generated mice with HBV transgenic and β-catenin activation livers. After three months, mice treated with MTX had remarkably lower tumor incidence, smaller maximum tumor volumes, and minimal effects on body weights compared to untreated mice.
Taken together, the findings of this study hint at the potential of MTX as an alternative to current first-line treatments for liver cancer with a verified CTNNB1 mutation. Satisfied with the results and with eyes on the future, Dr. Zhang concludes: “MTX is a promising chemotherapeutic agent for β-catenin-hyperactive liver cancer. Since repurposing MTX has the advantages of lower risk, shorter timelines, and less investment in drug discovery and development, a clinical trial is warranted to test its efficacy in the treatment of β-catenin mutant liver cancer.”
Let us hope that further studies and clinical trials pave the way to better outcomes for patients with liver cancer!
***
Reference
DOI: https://doi.org/10.1097/CM9.0000000000002816
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-09-20
The State Council of Higher Education for Virginia (SCHEV) approved Tuesday the creation of an undergraduate major for the University of Virginia’s School of Data Science, a landmark development for the four-year-old school, which was the first of its kind in the nation.
Prior to Tuesday’s announcement, undergraduates could obtain a minor in data science, while graduate students could pursue master’s or doctoral degrees. Now, the establishment of the B.S. in Data Science will allow UVA’s undergraduates to focus their studies on this emerging and growing interdisciplinary field.
“The B.S. in Data Science major is a major milestone ...
2023-09-20
Highlights:
Organisms, including viruses, live in the deepest, darkest places on the planet
Marine virologists analyzed sediment from the Mariana Trench, the deepest place on Earth, and identified a new bacteriophage
The phage infects Halomonas bacteria, which have been found in deep-sea environments and near hydrothermal vents
The study helps probe how phages and hosts evolve together in secluded, hostile environments
Washington, D.C. — The Mariana Trench, the deepest place on Earth, plunges nearly 11,000 meters at its lowest point on the floor ...
2023-09-20
A new Northwestern University-led study is changing the way astrophysicists understand the eating habits of supermassive black holes.
While previous researchers have hypothesized that black holes eat slowly, new simulations indicate that black holes scarf food much faster than conventional understanding suggests.
The study will be published on Wednesday (Sept. 20) in The Astrophysical Journal.
According to new high-resolution 3D simulations, spinning black holes twist up the surrounding space-time, ultimately ripping apart ...
2023-09-20
Florida Atlantic University’s María de los Ángeles Ortega, DNP, APRN, in the Christine E. Lynn College of Nursing, has been awarded a three-year, $1.3 million grant from the Administration for Community Living’s (ACL) Alzheimer’s Disease Program Initiative for a groundbreaking project designed to advance health equity and improve quality of life for individuals living with or at high risk for Alzheimer’s disease and related dementias (ADRD) and their family caregivers.
ACL was created around the fundamental principle that all people, regardless of age or disability, should be able to live independently ...
2023-09-20
A team of researchers, led by Professor Jungki Ryu in the School of Energy and Chemical Engineering at UNIST and Professor Soojin Park from Pohang University of Science and Technology (POSTECH), have achieved a significant breakthrough in the development of a hybrid silicon photocatalyst. This innovative catalyst utilizes solar power to produce hydrogen and high-value compounds efficiently, marking a major step forward in green hydrogen production technology.
The newly developed photocatalyst is both non-toxic and eco-friendly, addressing the limitations associated with ...
2023-09-20
As summer turns to fall, many people will be turning off the air conditioning and firing up heaters instead. But traditional heating and cooling systems are energy intensive, and because they typically run on fossil fuels, they aren’t sustainable. Now, by mimicking a desert-dwelling chameleon, a team reporting in ACS’ Nano Letters has developed an energy-efficient, cost-effective coating. The material could keep buildings cool in the summers — or warm in the winters — without additional energy.
Many ...
2023-09-20
Boulder, Colo., USA: The consequences of a warming climate frequently dominated the news this summer, from devastating wildfires and floods to deadly heat waves across the globe. Reducing harm from climate change is a challenging endeavor, and it requires comprehensive public education. Thus, the question arises: How can climate change science be made most accessible to the general population, as well as decision-makers and educators?
In a new paper published in the journal Geosphere, Steph Courtney and Karen McNeal explore the effects ...
2023-09-20
WHAT:
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has provided scientific and financial support throughout the lifecycle of this HIV vaccine concept and is contributing funding for this study.
VIR-1388 is designed to instruct the ...
2023-09-20
NEW YORK, NY – Sept. 20, 2023 – As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates. Grady Health System (Atlanta, GA), Meharry Medical College (Nashville, TN), St. Luke’s Health System (Boise, ID), the University of Colorado (Aurora, CO), and Wayne Health (Detroit, MI) join the University of Arizona/ Banner Health, West Virginia University Hospitals, Inc., and San Francisco Health Network/ University of California to help identify barriers to vaccination and find ...
2023-09-20
Mount Sinai’s Department of Rehabilitation and Human Performance has announced a $6.2 million grant from the Steven & Alexandra Cohen Foundation. The grant will expand the Cohen Center for Recovery From Complex Chronic Illnesses (CoRE) to encompass research and clinical care beyond long COVID to include “long Lyme Disease/Lyme+” as well as other infection-associated complex chronic illnesses.
This funding will be used for new research programs focusing on understanding and highlighting the key similarities and differences between long COVID; long Lyme disease/Lyme+, a collection of infection-associated ...
LAST 30 PRESS RELEASES:
[Press-News.org] A study published in Chinese Medical Journal reveals potential of methotrexate to treat liver cancer
The study provides evidence suggesting that this widely used chemotherapeutic drug could be repurposed for treating a subtype of hepatocellular carcinoma
